Data / Form D filings / Boundless Bio, Inc.
Boundless Bio, Inc.: Form D filings
Boundless Bio, Inc., a biotechnology company in San Diego, CA, filed 3 Form D notices with the SEC between 2020 and 2023. The latest, on August 15, 2023, reports $100 million sold of a $100 million offering to 26 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 9880 Campus Point Drive, Suite 120, San Diego, CA, 92121
- Phone
- (858) 766-9912
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1782303
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 15, 2023 | New notice | $100,000,000 | $100,000,000 | 26 | Apr 5, 2023 | sec.gov | |
| May 4, 2021 | New notice | $105,585,007 | $105,585,007 | 28 | Apr 23, 2021 | sec.gov | |
| Mar 12, 2020 | New notice | $52,500,000 | $23,232,507 | $29,267,493 | 23 | Aug 24, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Zachary D. Hornby | Director, Executive Officer | |
| Benjamin D. Cravatt, Ph.D. | Director | |
| Fabio D. Pucci, Ph.D. | Director | |
| Jakob D. Loven, Ph.D. | Director | |
| Jennifer D. Lew | Director | |
| Christine D. Brennan, Ph.D. | Director | |
| Jonathan D. Lim, M.D. | Director | |
| Kristina D. Burow | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Aug 14, 2023 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Boundless Bio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.